The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Spiolto Respimat contains the active ingredients tiotropium (as ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced regulatory authority approvals for Spiolto ® Respimat ® (tiotropium/olodaterol) in first ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced the publication of new data from the Phase IIIb OTEMTO ® 1&2 trials (NCT01964352 ...
The FINANCIAL — Boehringer Ingelheim on July 2 announced regulatory authority approvals for Spiolto Respimat (tiotropium/olodaterol) in first European countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results